Metabolite information |
|
HMDB ID | HMDB0010396 |
Synonyms |
1-(8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphocholine1-Eicsoate1-Eicsoatetraenoyl-glycero-3-phosphocholine1-Eicsoic acidLPC(20:4)LPC(20:4/0:0)LPC(20:4W3/0:0)LPC(20:4n3/0:0)LyPC(20:4)LyPC(20:4/0:0)LyPC(20:4W3/0:0)LyPC(20:4n3/0:0)LysoPC a C20:4LysoPC(20:4(8Z,11Z,14Z,17Z))LysoPC(20:4)LysoPC(20:4/0:0)LysoPC(20:4W3/0:0)LysoPC(20:4n3/0:0)Lysophosphatidylcholine(20:4)Lysophosphatidylcholine(20:4/0:0)Lysophosphatidylcholine(20:4W3/0:0)Lysophosphatidylcholine(20:4n3/0:0) |
Chemical formula | C28H50NO7P |
IUPAC name | (2-{[(2R)-2-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium |
CAS registry number | – |
Monoisotopic molecular weight | 543.332489471 |
Chemical taxonomy |
|
Super class | None |
Class | None |
Sub class | None |
Biological properties |
|
Pathways (Pathway Details in HMDB) |
|
Reference | Country | Specimen | Marker function | Participants (Case) | Participants (Control) | |||||||||
Cancer type | Stage | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | Type | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | ||||
Wan et al., 2021 | China | Serum | diagnosis | squamous cell carcinomas+adenocarcinomas | I, II | 48 | 21, 27 | 59.1 (38-75) | smoker, non-smoker | healthy | 30 | – | – | – |
Wan et al., 2021 | China | Serum | diagnosis | squamous cell carcinomas+adenocarcinomas | I, II | 48 | 21, 27 | 59.1 (38-75) | smoker, non-smoker | healthy | 30 | – | – | – |
Reference | Chromatography | Ion source | Positive/Negative mode | Mass analyzer | Identification level |
Wan et al., 2021 | LC | ESI | both | Q-TOF | – |
Wan et al., 2021 | LC | ESI | both | Q-TOF | – |
Reference | Data processing software | Database search |
Wan et al., 2021 | Progenesis QI 2.3 | HMDB, Metlin |
Wan et al., 2021 | Progenesis QI 2.3 | HMDB, Metlin |
Reference | Difference method | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
Wan et al., 2021 | PCA, OPLS-DA, Student’s t test | – | – | – | <0.05 | – | >1 |
Wan et al., 2021 | PCA, OPLS-DA, Student’s t test | – | – | – | <0.05 | – | >1 |
Reference | Classification method | Cutoff value | AUROC 95%CI | Sensitivity (%) | Specificity (%) | Accuracy (%) |
Wan et al., 2021 | – | – | – | – | – | – |
Wan et al., 2021 | – | – | – | – | – | – |